🇺🇸 FDA
Patent

US 7510710

Compositions of UCP inhibitors, Fas antibody, a fatty acid metabolism inhibitor and/or a glucose metabolism inhibitor

granted A61KA61K2039/505A61K39/39541

Quick answer

US patent 7510710 (Compositions of UCP inhibitors, Fas antibody, a fatty acid metabolism inhibitor and/or a glucose metabolism inhibitor) held by The Regents of the University of Colorado expires Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado
Grant date
Tue Mar 31 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K2039/505, A61K39/39541, A61P, A61P35/00